Heterozygous HNF1A-MODY mice exhibit hyperglucagonemia preceding insulin secretory defects

被引：0
|
作者：
Louvet, I. [1 ]
Acosta-Montalvo, A. [1 ]
Moreno-Lopez, M. [1 ]
Thevenet, J. [1 ]
Chiral, M. [2 ]
Delalleau, N. [1 ]
Gmyr, V. [1 ]
Kerr-Conte, J. [1 ]
Pattou, F. [1 ]
Pontoglio, M. [2 ]
Saponaro, C. [1 ]
Liston, A. [3 ,4 ]
Bonner, C. [1 ]
机构：
[1] Univ Lille, CHU Lille, Inst Pasteur Lille, INSERM,U1190,EGID, Lille, France
[2] Inst Necker Enfants Malades, Paris, France
[3] Katholieke Univ Leuven, VIB Ctr Brain & Dis Res, Leuven, Belgium
[4] Univ Cambridge, Cambridge, England
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
302
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [1] Low-dose treatment with sulfonylureas improves hyperglucagonemia after a glucose challenge in HNF1A-MODY individuals and Hnf1a-/- mice
    Saponaro, C.
    Spiliotis, I.
    Acosta-Montalvo, A.
    Anguelova, L.
    Thevenet, J.
    Chiral, M.
    Gmyr, V.
    Kerr-Conte, J.
    Pattou, F.
    Pontoglio, M.
    Owen, K. R.
    Bonner, C.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S162 - S162
  • [2] Lipoprotein composition in HNF1A-MODY: Differentiating between HNF1A-MODY and Type 2 diabetes
    McDonald, Tim J.
    McEneny, Jane
    Pearson, Ewan R.
    Thanabalasingham, Gaya
    Szopa, Magdalena
    Shields, Beverley M.
    Ellard, Sian
    Owen, Katharine R.
    Malecki, Maciej T.
    Hattersley, Andrew T.
    Young, Ian S.
    CLINICA CHIMICA ACTA, 2012, 413 (9-10) : 927 - 932
  • [3] A Rare Case of HNF1A-MODY
    Velayati, Sara
    Shanik, Michael
    Romao, Isabela J.
    DIABETES, 2022, 71
  • [4] Where to for precision treatment of HNF1A-MODY?
    Bonner, Caroline
    Saponaro, Chiara
    DIABETOLOGIA, 2022, 65 (11) : 1825 - 1829
  • [5] Where to for precision treatment of HNF1A-MODY?
    Caroline Bonner
    Chiara Saponaro
    Diabetologia, 2022, 65 : 1825 - 1829
  • [6] Meglitinide Analogues in Adolescent Patients With HNF1A-MODY (MODY 3)
    Becker, Marianne
    Galler, Angela
    Raile, Klemens
    PEDIATRICS, 2014, 133 (03) : E775 - E779
  • [7] Identification of circulating microRNAs in HNF1A-MODY carriers
    Bonner, C.
    Nyhan, K. C.
    Bacon, S.
    Kyithar, M. P.
    Schmid, J.
    Concannon, C. G.
    Bray, I. M.
    Stallings, R. L.
    Prehn, J. H. M.
    Byrne, M. M.
    DIABETOLOGIA, 2013, 56 (08) : 1743 - 1751
  • [8] Variants influencing age at diagnosis of HNF1A-MODY
    Agnieszka H. Ludwig-Słomczyńska
    Michał T. Seweryn
    Piotr Radkowski
    Przemysław Kapusta
    Julita Machlowska
    Stepanka Pruhova
    Daniela Gasperikova
    Christine Bellanne-Chantelot
    Andrew Hattersley
    Balamurugan Kandasamy
    Lisa Letourneau-Freiberg
    Louis Philipson
    Alessandro Doria
    Paweł P. Wołkow
    Maciej T. Małecki
    Tomasz Klupa
    Molecular Medicine, 2022, 28
  • [9] Outmoded by MODY? A Case Report of HNF1A-MODY in Paediatric Stroke
    Siese, Thomas
    Hickingbotham, Hannah
    Eggers, Anne
    Alins-Sahun, Yolanda
    Bowen, Philippa
    Hamilton-Shield, Julian
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 205 - 205
  • [10] Treatment of young patients with HNF1A mutations (HNF1A-MODY)
    Raile, K.
    Schober, E.
    Konrad, K.
    Thon, A.
    Grulich-Henn, J.
    Meissner, T.
    Woelfle, J.
    Scheuing, N.
    Holl, R. W.
    DIABETIC MEDICINE, 2015, 32 (04) : 526 - 530
12345